CPHI 2026 | Nuvisan, the Science CRO

A female scientist wearing a lab coat is manipulating some glass tubes close to an HPLC system

Collaborating with you to advance molecules into drug products

Our CMC services help you navigate all aspects of pharmaceutical development:

Process: development and scale-up
Analytics: large and small molecules
Formulation of liquid and semi-solid
Clinical trial supply
EU-QP release
Troubleshooting (e.g., impurities, ICH M7 assessment, nitrosamines, solid form studies)
Integrated dermatology solutions.

Simplify your CMC journey today

Your proactive, dedicated partner from drug substance to commercial drug product and beyond. We offer flexibility and a willingness to adapt to your needs, for a strong, trusted and long-term relationship.

3 locations providing integrated GxP value-chain solutions in Germany and France, from early development to commercial
>200 team members: industry-experienced scientists, pharmacists and lab professionals enhancing efficiency, compliance and data quality to safely and effectively support your products to the market
40 years in the industry serving small biotech to big pharma organisations and projects
State-of-the-art technology and the capability to provide a unique combination of technologies and know-how
Strong project management – providing a solution-oriented mindset.

Every project is unique, so why settle for a one-size-fits-all approach? We tailor our services according to your needs:

Scientist wearing gloves assembling molecular structure with glass atoms in a laboratory setting

Route scouting
Process development
API manufacturing under GMP
Tox & GMP batch manufacturing 0.1 kg up to 10 kg
HPAPI up to OEL 0.1 µg/m³.
Impurities identification, isolation or synthesis

What our clients say
“[...] We highly value the extensive expertise with which Nuvisan supports Bayer’s Pharma CMC development functions, encompassing small-scale chemical synthesis, analytical testing, as well as development and manufacturing of first in human formulations. Supported by robust project management capabilities, project execution is consistently well aligned across disciplines and sites. This high level of professionalism has been demonstrated across multiple projects and has contributed significant added value to our pharmaceutical development pipeline.

Especially Nuvisan’s strong commitment and flexibility have been acknowledged by several project teams and represent the fundamental pillars of this successful partnership.”

Dr. Guido Wegener
Senior Expert External CMC Analytics
Bayer, Germany